March 06, 2023
From the makers of Visian ICL comes EVO Visian ICL, an Implantable Collamer™ Lens that corrects common vision problems such as nearsightedness (myopia) and astigmatism. Collamer is a biocompatible material that works in harmony with the eye. The lens, which is slightly smaller than a typical contact lens, is implanted in the eye during a 20 to 30-minute procedure. Unlike laser vision correction surgeries that permanently change the shape of your cornea, the EVO Visian ICL procedure is additive, meaning that no corneal tissue is removed. Worldwide, more than 1 million EVO Visian ICL lenses have been implanted.
At Kremer Eye Center, we have performed over 3,000 Visian surgeries, one of the highest volumes in the country. Our Kremer team was also a part of the FDA trial to get EVO approved in America.
Dr. Aronsky was the first surgeon to implant the Visian EVO lens on the East Coast. He says “the Visian ICL surgery is one of the most rewarding procedures we perform. We’ve been doing it since the FDA approval in 2006 and have been one of the busiest Visian ICL practices in the country. When we were asked to participate in the most recent FDA trial for their newest lens, the EVO lens, we were honored. We are thrilled that the FDA just approved this lens and we are excited to be one of the first practices in the country to implant them.”
Patients who are candidates for the ICL procedure and are seeking a vision solution that allows them the freedom of less dependence on glasses or contact lenses. The advantages of EVO Visian ICL include:
Patients who want a flexible and biocompatible vision correction option, as well as many patients who are not candidates for laser vision correction, find that Visian EVO ICL is the right procedure for them.
Ideal candidates for EVO Visian ICL:
EVO Visian ICL is an outpatient procedure that typically takes 20 to 30 minutes. After an initial exam with your ophthalmologist to determine that the EVO ICL is right for you, you will schedule your procedure. On the day of the procedure, your eyes will be numbed with an anesthetic eye drop and your refractive surgeon will implant the ICL between the iris (colored part of the eye) and the natural lens. Your surgeon will likely schedule a follow-up appointment on the same day as the procedure.
The EVO Visian ICL is intended to provide permanent vision correction, but it can be removed or upgraded by your surgeon. Patients should not feel the lens as it does not adhere to any structures within the eye and does not move once in place. The lens is placed behind your iris where only your eye doctor will be able to detect it.
Any medical procedure has certain risks associated with it. Potential complications of the EVO ICL procedure, although rare, include inflammation, an increase in eye pressure, or the need for an additional procedure, like an ICL exchange. While these potential risks are mitigated as much as possible, they can all typically be addressed early and without long-term side effects.
The EVO Visian ICL lens is intended to correct/reduce nearsightedness between -3.0 D up to -20.0 D and treat astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before. Since the implantation of the EVO Visian ICL is a surgical procedure, before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. Complications, although rare, may include the need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts. You should NOT have EVO Visian ICL surgery if your doctor determines that 1) the shape of your eye is not appropriate, 2) you do not meet the minimum endothelial cell density for your age at the time of implantation, 3) you have moderate to severe glaucoma, 4) your vision is not stable; or 5) if you are pregnant or nursing.
For additional information with potential benefits, risks, and complications please visit DiscoverICL.com
Here at Kremer, our patient’s well-being is our priority. Our dedicated team of surgeons and staff always makes an effort to create a safe and secure environment where you can easily access care comfortably and confidently.
Kremer Eye Center